Loading clinical trials...
Loading clinical trials...
STUDY TO EVALUATE THE ROLE OF T CELL-DYSFUNCTION IN SYMPTOMS ASSOCIATED WITH LONG COVID, LYME DISEASE AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME USING THE VIRAXIMMUNE FLUOROSPOT T CELL ASSAY
Conditions
Locations
3
United Kingdom
Monklands University Hospital, NHS
Airdrie, United Kingdom
Glasgow and Clyde NHS
Glasgow, United Kingdom
Raigmore Hospital, Inverness
Inverness, United Kingdom
Start Date
December 10, 2024
Primary Completion Date
June 1, 2026
Completion Date
June 1, 2026
Last Updated
December 4, 2025
NCT06631287
NCT06871293
NCT06932237
NCT06721949
NCT06511050
NCT06511063
Lead Sponsor
ViraxBio Labs
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions